A cohort study of sex differences and prognostic biomarkers in colerctal cancer

Artikelnummer: sg9789187449925

Kategorie: Medizin und Pflege


25,17 €

inkl. 7% USt. ,

Lieferzeit: 6 - 7 Werktage

Stk


Accumulating evidence indicates that CRC is a heterogeneous disease, which affects outcome beyond what can be predicted by disease stage and other conventional prognostic factors. Thus, there is a great need to identify new biomarkers to enable a more accurate prognostication, and to help select patients for adjuvant treatment. In this thesis, the associations of a series of putative biomarkers with survival, treatment response and clinicopathological factors were investigated in a large cohort of incident CRC, with special attention to sex differences. Tumours from 557 incident cases of CRC, assembled in tissue microarrays, were evaluated for expression of cyclin D1, mismatch repair proteins, beta-catenin and epidermal growth factor receptor (EGFR) by immunohistochemistry, and further, EGFR gene copy number (GCN) alterations by brightfield double-in situ hybridization. In addition, KRAS and BRAF mutational status was assessed by pyrosequencing. The results demonstrate several relevant associations of the investigative biomarkers with prognosis and treatment response in CRC. Moreover, substantial sex differences in the clinicopathological correlates and prognostic significance of some of the biomarkers were observed.

Autor: Sakarias Wangefjord
Seitenzahl: 144
Verlag: Media-Tryck
Sprache: Englisch
Format: Geheftet
ISBN: 9789187449925
Veröffentlichungsdatum: 20140130
Produktnummer Verlag: 4284
Lieferinfo: Lagerware beim Lieferant in Schweden.
In der Regel können wir innerhalb von 6-7 Werktagen liefern.
Die Lieferzeit hängt aber davon ab, an welchem Wochentag Sie bestellen.
Bitte beachten, der Artikel kann trotzdem ausverkauft werden.
Wir erhalten wöchentlich eine Info vom Lieferant und aktualisieren danach.